ETF PROAI
LABUDIREXION DAILY S&P BIOTECH BULL 3X SHARESINDEX

DIREXION DAILY S&P BIOTECH BULL 3X SHARES

$265.79+1.84% vs prior close
10034252-WK

Price through Sep 30 · Flows through Sep 30. Figures use the latest available records, not a live quote. Fund details retrieved Oct 1. Holdings snapshot retrieved Oct 1.

Price & daily flows
301.8249.2196.6265.79DAILY NET FLOWMar 31Jun 1Jul 30Sep 30

SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 6M SHOWN · NET −$251M OVER THIS RANGE

The desk’s read

Money keeps arriving — +$107M of net inflows over the past month, about 18.0% of the fund's asset base, while the price has returned +66.8% so far this year.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$594Massets under management
—expense ratio
+$107Mnet flow, trailing month
340Kavg daily volume, 30 days
134holdings · US-domiciled
2023listed November 27, 2023 · beta 3.13
Sector weights
Healthcare100%
Health Technology98.69%
Other82.33%
Health Services0.83%
Cash0.48%
PORTFOLIO COMPOSITION, LATEST DISCLOSURE
Country weights
United States97.18%
Other82.68%
United Kingdom1.29%
Switzerland1.25%
Ireland0.27%
Bermuda0.06%
Netherlands0.06%
PORTFOLIO COMPOSITION, LATEST DISCLOSURE
Performance
1 week+5.3%
1 month-14.8%
3 months-12.4%
6 months+60.0%
YTD+66.8%
1 year+164.6%
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week+$13M
1 month+$107M
3 months+$1M
YTD−$477M
1 year−$911M

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

Monthly net flows
OctNovDecJanFebMarAprMayJunJulAugSep
DAILY CREATION/REDEMPTION RECORDS, TRAILING TWELVE MONTHS
The risk read
77%realized volatility, 30 days (annualized)
84%realized volatility, 1 year
-30.7%deepest fall from a peak, 1 year
-22.2%latest close versus that peak

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
998calls · latest snapshot
1Kputs · latest snapshot
1.45put/call ratio
291Kshares traded
The case against LABU

Due diligence cuts both ways. These funds sit on the same shelf and beat LABU on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
IBRN iShares Neuroscience and Healthcare ETF0.47%$7133.04T+$136K12015750× the assets · +$136K in over the monthHead-to-head
EFRA iShares Environmental Infrastructure and Industrials ETF0.47%$5553.16T+$2K9354415× the assets · +$2K in over the monthHead-to-head
ETEC iShares Trust - iShares Breakthrough Environmental Solutions ETF0.47%$3999.92T+$2K6737946× the assets · +$2K in over the monthHead-to-head
GDMN WisdomTree Efficient Gold Plus Gold Miners Strategy Fund0.45%$9897.51T—16672556× the assetsHead-to-head
EFAS Global X MSCI SuperDividend EAFE ETF0.56%$9572.80T—16125575× the assetsHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.
InstrumentsHarvest substitutesTrade cost at $1MClient tearsheetStress this fund
THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.